Lates News

AI fast news, Dongguan Securities released a research report on April 24 stating that it has given a buy rating to Aier Ophthalmology (300015.SZ). The main reasons for the rating include: 1) Continuous enhancement of internal driving force, focusing on the development of core business; 2) Positive growth in revenue in most domestic regions; 3) China has great potential for growth in demand for ophthalmic medical services. (Daily Economic News)